GeneBio Systems
Recombinant human CDNF Protein(Fc Tag)
Recombinant human CDNF Protein(Fc Tag)
SKU:PDMH100259
Couldn't load pickup availability
Size:100μg
Storage:Generally, lyophilized proteins are stable for up to 12 months when stored at -20 to -80℃. Reconstituted protein solution can be stored at 4-8℃ for 2-7 days. Aliquots of reconstituted samples are stable at < -20℃ for 3 months.
Shipping:This product is provided as lyophilized powder which is shipped with ice packs.
Exp date:12 months
Category ID_II:Recombinant Proteins
Category ID_III:Cytokines
Abbreviation:CDNF
Target Synonym:Arginine rich mutated in early stage tumors like 1;ARMET L1;ARMET like protein 1;ARMET-like protein 1;ARMETL 1;CDNF;CDNF;Cerebral dopamine neurotrophic factor;Conserved dopamine neurotrophic factor
Research Areas:Neuroscience
Conjugation:
Target Species:human
Expression Host:Mammalian
Application:
Fusion tag:C-Fc
UNIProt ID:Q49AH0
Accession:Q49AH0
Background:Cerebral Dopamine Neurotrophic Factor (CDNF), also known as ARMETL1 (ARMET-like protein 1), is a secreted protein with eight conserved cysteine residues, predicting a unique protein fold and defining a new, evolutionarily conserved protein family. CDNF is a novel neurotrophic factor with strong trophic activity on dopaminergic neurons comparable to that of glial cell line-derived neurotrophic factor (GDNF). CDNF/ARMETL1 is a evolutionary conserved protein which can protect and restore the function of dopaminergic neurons in the rat model of Parkinson's disease, suggesting that CDNF might be beneficial for the treatment of Parkinson's disease. CDNF is widely expressed in neurons in several brain regions including cerebral cortex, hippocampus, substantia nigra, striatum and cerebellum. Human CDNF is glycosylated and secreted from transiently transfected cells. CDNF promotes the survival, growth, and function of dopamine-specific neurons and is expressed in brain regions that undergo cocaine-induced neuroplasticity.
Concentration:
Activity:Not validated for activity
Sequence:Met1-Leu187
Purity: > 90% as determined by reducing SDS-PAGE.
Formulation:Lyophilized from a 0.2 μm filtered solution in PBS with 5% Trehalose and 5% Mannitol.
Reconstitution:It is recommended that sterile water be added to the vial to prepare a stock solution of 0.5 mg/mL. Concentration is measured by UV-Vis.
Endotoxin:< 1.0 EU/mg of the protein as determined by the LAL method.
Calculated MW: 45.4 kDa
ObservedMW:40-50 kDa
